中医药调节肠道菌群防治大肠癌的研究进展
Research Progress on Traditional Chinese Medicine in Regulating Gut Microbiota for the Prevention and Treatment of Colorectal Cancer
DOI: 10.12677/tcm.2026.154212, PDF,   
作者: 王俊凤：重庆医科大学附属永川中医院，重庆；欧 畅*：重庆医科大学附属永川中医院肿瘤科，重庆
关键词: 中医药；肠道菌群；大肠癌；综述；Traditional Chinese Medicine； Gut Microbiota； Colorectal Cancer； Review
摘要: 肠道菌群失衡已被证实是大肠癌发生的重要危险因素之一。近年来，研究证实中医药防治大肠癌的作用机制与其调节肠道菌群密切相关。本文结合近年来国内外相关研究成果，从肠道菌群与大肠癌的关联机制、中医药调节肠道菌群防治大肠癌的理论基础、单味中药及有效成分、中药复方、针灸及其他中医外治法的研究进展等方面进行系统综述，以期为中医药基于调节肠道菌群防治大肠癌的深入研究、临床应用及新药研发提供参考依据。
Abstract: Imbalance of gut microbiota has been confirmed as one of the important risk factors for the occurrence of colorectal cancer. In recent years, studies have demonstrated that the mechanism by which Traditional Chinese Medicine (TCM) prevents and treats colorectal cancer is closely related to its regulation of gut microbiota. This article systematically reviews recent domestic and international research findings, encompassing the association mechanism between gut microbiota and colorectal cancer, the theoretical basis of TCM in regulating gut microbiota for colorectal cancer prevention and treatment, as well as research progress on single herbs and active components, TCM formulas, acupuncture, and other external therapies of TCM. The aim is to provide references for further research, clinical application, and new drug development in TCM-based regulation of gut microbiota for the prevention and treatment of colorectal cancer.
文章引用：王俊凤, 欧畅. 中医药调节肠道菌群防治大肠癌的研究进展[J]. 中医学, 2026, 15(4): 302-308. https://doi.org/10.12677/tcm.2026.154212

参考文献

[1] 吴琪, 范伯男, 李岩. 2022全球癌症统计报告分析解读: 中国与世界癌症疾病负担与流行趋势[J]. 诊断学理论与实践, 2025, 24(2): 135-145.
[2] Yadav, D., Sainatham, C., Filippov, E., Kanagala, S.G., Ishaq, S.M. and Jayakrishnan, T. (2024) Gut Microbiome-Colorectal Cancer Relationship. Microorganisms, 12, Article 484. [Google Scholar] [CrossRef] [PubMed]
[3] 田婷婷, 刘璇, 陈果, 等. “从菌论治”结直肠癌的初步探讨[J]. 世界科学技术-中医药现代化, 2020, 22(7): 2517-2521.
[4] 朱浩澜, 刘宇婧, 季光, 等. 基于肠道菌群的中药复方与单体在结直肠癌防治中的研究进展[J]. 上海中医药杂志, 2025, 59(9): 85-90.
[5] Cuevas-Ramos, G., Petit, C.R., Marcq, I., Boury, M., Oswald, E. and Nougayrède, J. (2010) Escherichia coli Induces DNA Damage in Vivo and Triggers Genomic Instability in Mammalian Cells. Proceedings of the National Academy of Sciences of the United States of America, 107, 11537-11542. [Google Scholar] [CrossRef] [PubMed]
[6] Nougayrède, J., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., et al. (2006) Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells. Science, 313, 848-851. [Google Scholar] [CrossRef] [PubMed]
[7] Pleguezuelos-Manzano, C., Puschhof, J., Rosendahl Huber, A., van Hoeck, A., Wood, H.M., Nomburg, J., et al. (2020) Mutational Signature in Colorectal Cancer Caused by Genotoxic pks+ E. Coli. Nature, 580, 269-273. [Google Scholar] [CrossRef] [PubMed]
[8] Rubinstein, M.R., Wang, X., Liu, W., Hao, Y., Cai, G. and Han, Y.W. (2013) Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via Its Fada Adhesin. Cell Host & Microbe, 14, 195-206. [Google Scholar] [CrossRef] [PubMed]
[9] Bashir, A., Miskeen, A.Y., Hazari, Y.M., Asrafuzzaman, S. and Fazili, K.M. (2016) Fusobacterium nucleatum, Inflammation, and Immunity: The Fire within Human Gut. Tumor Biology, 37, 2805-2810. [Google Scholar] [CrossRef] [PubMed]
[10] Xie, M., Yuan, K., Zhang, Y., Zhang, Y., Zhang, R., Gao, J., et al. (2025) Tumor-Resident Probiotic Clostridium butyricum Improves aPD-1 Efficacy in Colorectal Cancer Models by Inhibiting IL-6-Mediated Immunosuppression. Cancer Cell, 43, 1885-1901.e10. [Google Scholar] [CrossRef] [PubMed]
[11] Weis, A.M., Bauer, K.M., Tang, W.W., Stephen-Victor, E., Bell, R., Brown, D.G., et al. (2025) A Capsular Polysaccharide from a Healthy Human Microbiota Member Activates a Lag-3-Nk Cell Axis to Restrain Colon Cancer and Augment Immunotherapy. Cell Reports, 44, 116172. [Google Scholar] [CrossRef] [PubMed]
[12] Nie, X., Zhang, T., Huang, X., Gu, C., Zuo, W., Fu, L., et al. (2024) Novel Therapeutic Targets: Bifidobacterium-Mediated Urea Cycle Regulation in Colorectal Cancer. Cell Biology and Toxicology, 40, Article No. 64. [Google Scholar] [CrossRef] [PubMed]
[13] Jia, D., Wang, Q., Qi, Y., Jiang, Y., He, J., Lin, Y., et al. (2024) Microbial Metabolite Enhances Immunotherapy Efficacy by Modulating T Cell Stemness in Pan-Cancer. Cell, 187, 1651-1665.e21. [Google Scholar] [CrossRef] [PubMed]
[14] 张洪源, 任广振, 黄建政, 等. 健脾类中药多糖对脾虚相关病症肠道菌群影响研究现状[J]. 中国中医药信息杂志, 2022, 29(2): 147-151.
[15] 蔡华珠, 洪菲萍, 纪立金, 等. “正气存内, 邪不可干”的内涵及运用探析[J]. 中华中医药杂志, 2015, 30(4): 987-989.
[16] 孔宪斌, 杨振弢, 彭莹莹, 等. 基于“虚、毒、瘀”浅谈结直肠癌的病机和治疗[J]. 环球中医药, 2020, 13(12): 2081-2084.
[17] Wei, X., Wang, F., Tan, P., Huang, H., Wang, Z., Xie, J., et al. (2024) The Interactions between Traditional Chinese Medicine and Gut Microbiota in Cancers: Current Status and Future Perspectives. Pharmacological Research, 203, Article ID: 107148. [Google Scholar] [CrossRef] [PubMed]
[18] 李晶, 侯俊明, 罗璐, 等. 基于“治未病”思想的直肠癌防治探讨[J]. 现代中医药, 2017, 37(2): 68-70.
[19] 沈梦, 张烨, 陈凯, 等. 中药复方防治结直肠腺瘤研究进展[J]. 中国实验方剂学杂志, 2024, 30(19): 64-72.
[20] 谭雅彬. 中药治疗大肠癌术后脾肾阳虚证患者疗效及对肠道菌群影响的研究[D]: [博士学位论文]. 北京: 北京中医药大学, 2021.
[21] Yan, S., Chang, J., Hao, X., Liu, J., Tan, X., Geng, Z., et al. (2022) Berberine Regulates Short-Chain Fatty Acid Metabolism and Alleviates the Colitis-Associated Colorectal Tumorigenesis through Remodeling Intestinal Flora. Phytomedicine, 102, Article ID: 154217. [Google Scholar] [CrossRef] [PubMed]
[22] 张明玥, 夏玮, 韦珊珊, 等. 小檗碱在结直肠癌治疗中的作用机制研究进展[J]. 中草药, 2024, 55(7): 2491-2502.
[23] Zhang, Q., Deng, S., Sun, Y., Lv, J., Bukvicki, D., Liu, Y., et al. (2026) Chlorogenic Acid Improves DSS-Induced Colitis in Mice by Regulating the Gut Microbiota. Food & Function, 17, 1645-1659. [Google Scholar] [CrossRef] 
[24] 苏辉, 司明明, 周军, 等. 绿原酸及其代谢产物抗结肠癌作用机制的研究进展[J]. 广西医学, 2023, 45(1): 98-101.
[25] Zhou, H., Zhuang, Y., Liang, Y., Chen, H., Qiu, W., Xu, H., et al. (2025) Curcumin Exerts Anti-Tumor Activity in Colorectal Cancer via Gut Microbiota-Mediated CD8+ T Cell Tumor Infiltration and Ferroptosis. Food & Function, 16, 3671-3693. [Google Scholar] [CrossRef] [PubMed]
[26] Bai, X., Duan, Z., Deng, J., Zhang, Z., Fu, R., Zhu, C., et al. (2025) Ginsenoside Rh4 Inhibits Colorectal Cancer via the Modulation of Gut Microbiota-Mediated Bile Acid Metabolism. Journal of Advanced Research, 72, 37-52. [Google Scholar] [CrossRef] [PubMed]
[27] 刘雷蕾, 马淑然. 基于肠道菌群介导的炎性反应研究黄芪多糖对结肠炎相关癌症的作用[J]. 世界中医药, 2021, 16(2): 226-237.
[28] Chen, Z., Ni, W., Yang, C., Zhang, T., Lu, S., Zhao, R., et al. (2018) Therapeutic Effect of Amomum villosum on Inflammatory Bowel Disease in Rats. Frontiers in Pharmacology, 9, Article 639. [Google Scholar] [CrossRef] [PubMed]
[29] Chen, L., Zhao, S., Chen, Q., Luo, P., Li, X., Song, Y., et al. (2025) Poria cocos Polysaccharides Ameliorate AOM/DSS-Induced Colorectal Cancer in Mice by Remodeling Intestinal Microbiota Composition and Enhancing Intestinal Barrier Function. International Journal of Biological Macromolecules, 315, Article ID: 144477. [Google Scholar] [CrossRef] [PubMed]
[30] 汪舒云, 谢曼丽, 孙可向, 等. 参苓白术散对大肠癌移植瘤模型小鼠化学疗法后肠道黏膜屏障的影响[J]. 上海中医药杂志, 2023, 57(4): 57-64.
[31] 曹晨, 张翔, 顾芳红, 等. 参苓白术散治疗脾虚湿困型晚期结直肠癌疗效及对肠道菌群、免疫功能、生活质量的影响[J]. 现代中西医结合杂志, 2025, 34(2): 190-196.
[32] 欧阳庆武, 费雁, 魏运姣, 等. 四君子汤对结肠癌小鼠肠道菌群及免疫功能的调节作用[J]. 中国老年学杂志, 2021, 41(21): 4819-4823.
[33] 章斐然, 谢澳斯, 张金海, 等. 四君子汤对大肠癌术后化疗患者肠道菌群及免疫功能影响的临床研究[J]. 汕头大学医学院学报, 2020, 33(4): 206-208.
[34] 郭礼. 四君子汤联合化疗对大肠癌患者具核梭杆菌的影响及临床疗效观察[D]: [硕士学位论文]. 咸阳: 陕西中医药大学, 2021.
[35] 王楠, 方兴刚, 廖莎, 等. 葛根芩连汤基于Wnt/β-Catenin信号通路对结肠癌模型大鼠肠道菌群作用机制研究[J]. 辽宁中医药大学学报, 2023, 25(2): 49-53.
[36] 谢青, 林湘萍, 伍鋆, 等. 葛根芩连汤调节肠道菌群抑制大肠癌的作用机制研究[J]. 四川中医, 2025, 43(3): 126-131.
[37] Li, Y., Li, Z., Xie, C., Fan, J., Lv, J., Xu, X., et al. (2020) Gegen Qinlian Decoction Enhances Immunity and Protects Intestinal Barrier Function in Colorectal Cancer Patients via Gut Microbiota. World Journal of Gastroenterology, 26, 7633-7651. [Google Scholar] [CrossRef] [PubMed]
[38] 周洪立, 陈海彬, 庄育培, 等. 补地参连方调节肠道菌群及肿瘤相关巨噬细胞表型转换发挥抗结直肠癌效应[J]. 南京中医药大学学报, 2025, 41(4): 442-455.
[39] Huang, M., Zhang, Y., Ni, M., Shen, M., Tao, Y., Shen, W., et al. (2024) Shen-Bai-Jie-Du Decoction Suppresses the Progression of Colorectal Adenoma to Carcinoma through Regulating Gut Microbiota and Short-Chain Fatty Acids. Chinese Medicine, 19, Article No. 149. [Google Scholar] [CrossRef] [PubMed]
[40] 程玉莲. 健脾解毒方加减在脾气亏虚证晚期结直肠癌化疗患者中的应用效果[J]. 中国肛肠病杂志, 2021, 41(8): 11-13.
[41] 赵敏, 刘峰林, 马琳, 郑美玲. 益气健脾汤联合卡培他滨 + 奥沙利铂方案对结直肠癌患者免疫功能、肠道菌群的影响[J]. 中国当代医药, 2025, 32(14): 131-134.
[42] 田浩然, 周钰点, 陆大敏, 等. 电针对肥胖大鼠小肠炎性反应及肠道菌群的影响[J]. 针刺研究, 2024, 49(9): 949-956.
[43] 周谦, 孟宁, 许建多. 温针灸对结直肠癌肠造口还纳术后患者肠道菌群及肛门功能的影响[J]. 广州中医药大学学报, 2024, 41(9): 2367-2373.
[44] 宋亚芳, 张晓梅, 蒋诗媛, 等. 从肠道菌群探讨艾灸“足三里”“肝俞”穴抑制裸鼠结肠癌细胞肝转移机制[J]. 世界科学技术-中医药现代化, 2024, 26(12): 3118-3126.
[45] 杨得振, 侯俊明, 贾勇, 等. 莪黄汤保留灌肠对结直肠癌术后肠道菌群及肠黏膜通透性的影响[J]. 中医药导报, 2018, 24(10): 46-49.